Unusual 11 Mid-Day Movers 05/10: (ADY) (INSP) (RPRX) Higher; (SGI) (WFR) (ARX) Lower
Tweet
Share
E-mail
Get Alerts ADY Hot Sheet
Join SI Premium – FREE
Feihe International (NYSE: ADY) 39.5% HIGHER; reported Q1 EPS of $0.40, $0.16 better than the analyst estimate of $0.24. Revenue for the quarter came in at $62.9 million versus the consensus estimate of $83 million.
Silicon Graphics (Nasdaq: SGI) 27.1% LOWER; reported Q3 EPS of $0.11, $0.14 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $199.4 million versus the consensus estimate of $189.9 million. Sees FY2012 EPS of $-0.30-$-0.15, versus the consensus of $0.24. Sees FY2012 revenue of $750-$770 million, versus the consensus of $772.90 million. Sees Q4 2012 EPS of $-0.52-$-0.37, versus the consensus of $0.16. Silicon Graphics sees Q4 2012 revenue of $177-$197 million, versus the consensus of $208.87 million.
MEMC Electronic Materials (NYSE: WFR) 25.2% LOWER; reported Q1 EPS of ($0.26), $0.10 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $523.8 million versus the consensus estimate of $496.44 million.
InfoSpace, Inc. (Nasdaq: INSP) 24.2% HIGHER; reported Q1 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $115.7 million versus the consensus estimate of $11.23 million. Sees Q2 2012 EPS of $0.13-$0.16, versus the consensus of $0.06. Sees Q2 2012 revenue of $92.5-$96.5 million, versus the consensus of $88.5 million.
Aeroflex Holdings (NYSE: ARX) 21.3% LOWER; reported Q3 EPS of ($0.08), $0.24 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $162.3 million versus the consensus estimate of $173.33 million. Sees Q4 2012 EPS of $0.20-$0.27, versus the consensus of $0.32. Aeroflex Holdings sees Q4 2012 revenue of $180-$195 million, versus the consensus of $201.6 million.
Repros Therapeutics (Nasdaq: RPRX) 20.6% HIGHER; today announced it has held a meeting with the Division of Reproductive and Urologic Products (DRUP) to agree upon the registration requirements for the Company's Androxal oral therapy for the treatment of secondary hypogonadism. Repros believes secondary hypogonadism is responsible for over 90% of the incidence of low testosterone in the United States.
Keryx Biopharma (Nasdaq: KERX) 17.2% HIGHER; following Q1 results on Tuesday afternoon, the stock was upgraded to Buy at both Roth Capital and Ladenburg Thalmann earlier.
Virtusa Corporation (Nasdaq: VRTU) 17.2% HIGHER; reported Q4 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $74.4 million. Sees Q1 2012 EPS of $0.20-$0.24, versus the consensus of $0.23. Virtusa Corporation sees Q1 2012 revenue of $75-$77 million, versus the consensus of $77.06 million. Sees FY2013 EPS of $0.95-$1.11, versus the consensus of $1.06. Virtusa Corporation sees FY2013 revenue of $314-$330 million, versus the consensus of $327.2 million.
DG FastChannel, Inc. (Nasdaq: DGIT) 19.6% LOWER; reported Q1 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $92.85 million versus the consensus estimate of $91.02 million.
Clean Diesel Tech (Nasdaq: CDTI) 19.5% LOWER; reported Q1 EPS of ($0.39), $0.10 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $17 million versus the consensus estimate of $16 million.
Zale (NYSE: ZLC) 13% HIGHER; breaking out over the $2.50 level today. Shares have bounced off the 50-day SMA.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Silicon Graphics (Nasdaq: SGI) 27.1% LOWER; reported Q3 EPS of $0.11, $0.14 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $199.4 million versus the consensus estimate of $189.9 million. Sees FY2012 EPS of $-0.30-$-0.15, versus the consensus of $0.24. Sees FY2012 revenue of $750-$770 million, versus the consensus of $772.90 million. Sees Q4 2012 EPS of $-0.52-$-0.37, versus the consensus of $0.16. Silicon Graphics sees Q4 2012 revenue of $177-$197 million, versus the consensus of $208.87 million.
MEMC Electronic Materials (NYSE: WFR) 25.2% LOWER; reported Q1 EPS of ($0.26), $0.10 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $523.8 million versus the consensus estimate of $496.44 million.
InfoSpace, Inc. (Nasdaq: INSP) 24.2% HIGHER; reported Q1 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $115.7 million versus the consensus estimate of $11.23 million. Sees Q2 2012 EPS of $0.13-$0.16, versus the consensus of $0.06. Sees Q2 2012 revenue of $92.5-$96.5 million, versus the consensus of $88.5 million.
Aeroflex Holdings (NYSE: ARX) 21.3% LOWER; reported Q3 EPS of ($0.08), $0.24 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $162.3 million versus the consensus estimate of $173.33 million. Sees Q4 2012 EPS of $0.20-$0.27, versus the consensus of $0.32. Aeroflex Holdings sees Q4 2012 revenue of $180-$195 million, versus the consensus of $201.6 million.
Repros Therapeutics (Nasdaq: RPRX) 20.6% HIGHER; today announced it has held a meeting with the Division of Reproductive and Urologic Products (DRUP) to agree upon the registration requirements for the Company's Androxal oral therapy for the treatment of secondary hypogonadism. Repros believes secondary hypogonadism is responsible for over 90% of the incidence of low testosterone in the United States.
Keryx Biopharma (Nasdaq: KERX) 17.2% HIGHER; following Q1 results on Tuesday afternoon, the stock was upgraded to Buy at both Roth Capital and Ladenburg Thalmann earlier.
Virtusa Corporation (Nasdaq: VRTU) 17.2% HIGHER; reported Q4 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $74.4 million. Sees Q1 2012 EPS of $0.20-$0.24, versus the consensus of $0.23. Virtusa Corporation sees Q1 2012 revenue of $75-$77 million, versus the consensus of $77.06 million. Sees FY2013 EPS of $0.95-$1.11, versus the consensus of $1.06. Virtusa Corporation sees FY2013 revenue of $314-$330 million, versus the consensus of $327.2 million.
DG FastChannel, Inc. (Nasdaq: DGIT) 19.6% LOWER; reported Q1 EPS of $0.05, $0.03 better than the analyst estimate of $0.02. Revenue for the quarter came in at $92.85 million versus the consensus estimate of $91.02 million.
Clean Diesel Tech (Nasdaq: CDTI) 19.5% LOWER; reported Q1 EPS of ($0.39), $0.10 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $17 million versus the consensus estimate of $16 million.
Zale (NYSE: ZLC) 13% HIGHER; breaking out over the $2.50 level today. Shares have bounced off the 50-day SMA.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Questor Technology signs LOI to acquire Emission Rx for up to C$3M
- Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss
- Aptevo raises $4.5M through warrant exercise and private placement
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Roth Capital, Ladenburg Thalmann Financial Services, Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
